FDA NDC Directory · JSON-LD · Markdown
NDC 0220-5181 · HUMAN OTC DRUG · PELLET
| Generic name | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|---|
| Labeler / Manufacturer | Boiron |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Dosage form / route | PELLET · ORAL |
| Active ingredients | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (8 [hp_X]/8[hp_X]) INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (8 [hp_X]/8[hp_X]) INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (8 [hp_X]/8[hp_X]) |
| Marketing started | 20260914 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).